Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease

Movement Disorders

Volumn 25, Issue 9, 2010, Pages 1143-1149

  Iijima, Mutsumi ^a   Osawa, Mikio ^a   Momose, Mitsuru ^a   Kobayakawa, Tatsu ^b   Saito, Sachiko ^c   Iwata, Makoto ^a   Uchiyama, Shinichiro ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c Saito Sachiko Taste and Smell Institute   (Japan)

Author keywords

MIBG; Odor stick identification test; Parkinson's disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; AMANTADINE; CABERGOLINE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; SELEGILINE; THREO 3,4 DIHYDROXYPHENYLSERINE; TRIHEXYPHENIDYL; (3 IODOBENZYL)GUANIDINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; DRUG UPTAKE; FEMALE; HEART DISEASE; HUMAN; JAPANESE; MALE; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; SMELLING; SMELLING DISORDER; SYMPATHETIC FUNCTION; ANALYSIS OF VARIANCE; AUTONOMIC NERVOUS SYSTEM DISEASES; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPLICATION; DIAGNOSTIC USE; HEART; INNERVATION; JAPAN; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; ODOR; OLFACTION DISORDERS; PHYSIOLOGY; PROCEDURES; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; AGED; ANALYSIS OF VARIANCE; AUTONOMIC NERVOUS SYSTEM DISEASES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HEART; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; OLFACTION DISORDERS; PARKINSON DISEASE; RADIOPHARMACEUTICALS; SMELL;

EID: 77955084454     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23001     Document Type: Article

References (39)

1. Becker G, Müller A, Braune S, et al. Early diagnosis of Parkinson's disease. J Neurol 2002;249 (Suppl 3):40-48.
2. Berg D. Marker for a preclinical diagnosis of Parkinson's disease as a basis for neuroprotection. J Neural Transm Suppl 2006;71: 123-132. (Pubitemid 351412114)
3. Siderowf A, Stern MB. Preclinical diagnosis of Parkinson's disease: are we there yet? Curr Neurol Neurosci Rep 2006;6:295-301.
4. Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24: 197-211.
5. Hawkes CH, Shephard BC, Daniel SE. Is Parkinson's disease a primary olfactory disorder? Q J Med 1999;92:473-480.
6. Montgomery EB Jr, Lyons K, Koller WC. Early detection of probable ideiopathic Parkinson's disease. II. A prospective application of a diagnostic test battery. Mov Disord 2000;15: 474-478.
7. Berendse HW, Booij J, Francot CM, et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relative with a decrease sense of smell. Ann Neurol 2001;50:34-41.
8. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BLF, Wolters EC, Berendse HW. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004;56:173-181. (Pubitemid 39037913)
9. Sommer U, Hummel T, Cormann, et al. Detaction of presymptomatic Parkinson's disease:combination smell tests, transcranial sonography, and SPECT. Mov Disord 2004;19:1196-1202. (Pubitemid 39429962)
10. Haehner A, Hummel T, Hummel S, et al. Olfactory loss may be a first sign of idiopathic Parkinson's disease. Mov Disord 2007; 22:839-842. (Pubitemid 46800106)
11. Verbaan D, Boesveldt S, van Rooden SM, et al. Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics? Neurology 2008;71:1877-1882.
12. Wieland D, Brawn L, Rogers W, et al. Myocardial imaging with a radioiodinated norepinephrine storage analogue. J Nucl Med 1981;22:22-31. (Pubitemid 11213140)
13. Orimo S, Ozawa E, Nakade S, et al. 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;67:189-194. (Pubitemid 29326950)
14. Spiegel J, Möllers MO, Jost WH, et al. FP-CIT and MIBG scintigraphy in early Parkinson's disease. Mov Disord 2005;20:552-561.
15. 123I-MIBG scntigraphy can assess the disease severity and phenotype of PD. J Neurol Sci 2004;15:105-111.
16. Suzuki M, Urashima M, Oka H, et al. Cardiac sympathetic denervation in bradykinesia-dominant Parkinson's disease. Neuro-Report 2007;18:1867-1870. (Pubitemid 350303768)
17. Yoshita M, Hayashi M, Hirai S. Decreased myocardinal accumulation of 123- meta- iodobenzyl guanidine in Parkinson's disease. Nucl Med Commun 1998;19:137-142. (Pubitemid 28189182)
18. 123I]MIBG separates Parkinson 'disease from multiple system atrophy. Neurology 1999;53:1020-1025.
19. Nagayama H, Hamamoto M, Ueda M, et al. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. J Neurol Neurosurg Psychiatry 2005;76:249-251. (Pubitemid 40143717)
20. Hughes AJ, Daniel SE, Blankson S, et al. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-148. (Pubitemid 23054795)
21. Spiegel J, Hellwig D, Samnick S, et al. Strietal FP-CIT uptake differs in the subtypes of early Parkinson's disease. J Neural Transm 2007;114:331-335.
22. Saito S, Ayabe-Kanamura S, Naito N, et al. Development of an odor identification test for Japanese people: verification of stick type and card type. J Odor Res Eng 2003;34:1-6.
23. Saito S, Ayabe-Kanamura S, Takashima Y, et al. Development of a smell identification test using a novel stick-type odor presentation kit. Chemical Senses 2006;31:379-391.
24. Momose M, Kobayashi H, Iguchi N, et al. Comparison of parameters of 123 I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy. Nucl Med Commun 1999;20:529-535. (Pubitemid 29509990)
25. Iijima M, Kobayakawa T, Saito S, et al. Smell identification in Japanese Parkinson's disease patients: using the odor stick identification test for Japanese subjects. Intern Med 2008:47:1887-1892.
26. Miyamoto T, Miyamoto M, Iwanami M, et al. Odor identification test as a indicator of idiopathic REM sleep behavior disorder. Mov Disord 2009;24:268-273.
27. Stern MB, Doty RL, Dotti M, et al. Olfactory function in Parkinson's disease subtypes. Neurology 1994;44:226-268.
28. Siderowf A, Newberg A, Chou KL, et al. [Tc-99m] TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson's disease. Neurology 2005;64:1716-1720.
29. Taki J, Yoshita M, Yamada M, et al. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: It can be a specific marker for Lewy body disease. Ann Nucl Med 2004;18:453-461. (Pubitemid 39410243)
30. Spiegel J, Hellwig D, Farmakis G, et al. Myocardinal sympathetic degeneration correlates with clinical phenotype of Parkinson's disease. Mov Disord 2007;22:1004-1008.
31. 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Mov Disord 2006;21:1975-1977.
32. 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism. J Neurol Neurosurg Psychiatry 2007;78:1250-1252.
33. Orimo S, Takashi A, Uchihara T, et al. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol 2007;17:24-30.
34. Fujishiro H, Frigerio R, Burnett M, et al. Cardiac sympathethic denervation correlates with clinical and pathologic stages of Parkinson' s disease. Mov Disord 2008;23:1085-1092.
35. Harding AJ, Stimson E, Henderson JM, et al. Clinical correlates of selective pathology in the amygdala of patients with Parkinson' disease. Brain 2002;125:2431-2445. (Pubitemid 35303503)
36. Hubbard PS, Esiri MM, Reading M, et al. Alpha-synuclein pathology in the olfactory pathways of dementia patients. J Anat 2007;211:117-124. (Pubitemid 47034515)
37. Huisman E, Uylings HB, Hoogland PV. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord 2004;19:687-692. (Pubitemid 39173024)
38. Westermann B, Wattendorf E, Schwerdtfeger U, et al. Functional imaging of the cerebral olfactory system in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2008;79: 19-24.
39. Hudry J, Thobois S, Broussolle E, et al. Evidence for deficiencies in perceptual and semantic olfactory processes in Parkinson's disease. Chem Senses 2003;28:537-543. (Pubitemid 39144846)